News in the Life Sciences Industry

BRUSSELS, Oct. 29, 2020 /PRNewswire/ -- UCB, a global biopharmaceutical company, today announced that new data on the investigational IL-17A and IL-17F inhibitor, bimekizumab, and TNF inhibitor, CIMZIA(® )(certolizumab pegol), in the management of moderate-to-severe plaque psoriasis are being... Read more ››

Continued solid performance and strong recovery of sales in Q3 2020

LEIDEN, Netherlands, Oct. 29, 2020 /PRNewswire/ -- Pharming Group N.V. (Euronext Amsterdam: PHARM) today announces it will hold an Extraordinary General Meeting (EGM) of Shareholders on Friday 11 December 2020 at 14:00 CET.

UTRECHT, Netherlands, Oct. 23, 2020 /PRNewswire/ -- The University of Groningen announces the publication of their International Waiting-list Randomized Controlled Trial (RCT) assessing the efficacy of Untire in the Read more ››

- Leniolisib is in a phase II/III registration-enabling study for the treatment of APDS, an ultra-rare and debilitating disease with no approved treatment

AMSTERDAM, Oct. 20, 2020 /PRNewswire/ -- This Dutch tech start-up, Safezone, has designed a device that aims to help prevent Covid-19 from spreading. The World Health Organization suggests the easiest way to stop the spread of Covid-19 is by physical distancing.